Newly designed drug compound to stop malaria in its tracks
26 May, 2021Scientists have developed a set of compounds designed to stop the malaria parasite being able to burst out of red blood cells — a process vital to its replication and life cycle.
Australia secures 25 million Moderna vaccines
13 May, 2021The government has secured 25 million doses of the Moderna COVID-19 vaccine to further diversify its vaccine portfolio, as well as to provide access to a booster or variant vaccine.
Electrically activated glue used to seal broken blood vessels
07 May, 2021A new device offers a way to seal tears and holes in blood vessels, using an electrically activated glue patch applied via a minimally invasive balloon catheter.
Lab-created heart valves grow with the recipient
03 May, 2021If confirmed in humans, the new heart valves could prevent the need for repeated valve replacement surgeries in thousands of children each year.
Vic announces $50m for domestic mRNA vaccine manufacturing
22 April, 2021The Victorian Government will provide $50m to establish mRNA vaccine and therapeutic manufacturing in Melbourne — the first such capability in the Southern Hemisphere.
Statins could help save Tasmanian devils
21 April, 2021Cholesterol-lowering drugs could help delay the spread of the deadly Tasmanian devil facial tumour disease and may help protect the endangered Australian marsupials from extinction.
Why do breast cancer drugs stop working?
15 April, 2021Although breast cancer can now be treated with drugs, many of these drugs mysteriously stop working after some time, causing a relapse. Researchers have now found out why this happens.
Hydrogel turns cancer cells back to cancer stem cells
07 April, 2021An innovative hydrogel — called a double network (DN) gel — can rapidly reprogram differentiated cancer cells into cancer stem cells.
Creating a genetic medicine manufacturing ecosystem
06 April, 2021 by Peter DavisAustralia has amazing scientists, respected worldwide, but do we have an ecosystem?
New nasal spray protects against COVID-19, common cold
29 March, 2021A new drug, designed to prime the immune system in the respiratory tract and currently in development for COVID-19, is also effective against rhinovirus.
Anti-inflammatory may help reduce chemo side effects
16 March, 2021Researchers have found that the anti-inflammatory drug anakinra substantially reduces the nerve symptoms for which vincristine chemotherapy is known.
Novavax vaccine efficacious against multiple COVID-19 strains
15 March, 2021Novavax has announced final efficacy of 96.4% against mild, moderate and severe disease caused by the original COVID-19 strain.
CSIRO secures a licence to develop medicinal cannabis
08 March, 2021The licence places CSIRO at the forefront of research into the development of new cannabis medicines, which should help people with a variety of conditions.
Dual-targeting drug developed for EBV-related cancers
05 March, 2021Hong Kong researchers have developed a novel drug for cancers associated with Epstein–Barr virus (EBV).
AstraZeneca vaccine arrives in Aus, Pfizer prevents infection
01 March, 2021The first doses of AstraZeneca's COVID-19 vaccine have arrived in Sydney, and new data suggests that Pfizer's vaccine can reduce asymptomatic infections.
